162 related articles for article (PubMed ID: 2806366)
1. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
[TBL] [Abstract][Full Text] [Related]
2. Diethyldithiocarbamate and disulfiram inhibit MPP+ and dopamine uptake by striatal synaptosomes.
Di Monte D; Irwin I; Kupsch A; Cooper S; DeLanney LE; Langston JW
Eur J Pharmacol; 1989 Jul; 166(1):23-9. PubMed ID: 2553428
[TBL] [Abstract][Full Text] [Related]
3. In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+ analog.
Rollema H; Booth RG; Castagnoli N
Eur J Pharmacol; 1988 Aug; 153(1):131-4. PubMed ID: 3265107
[TBL] [Abstract][Full Text] [Related]
4. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.
Bougria M; Vitorica J; Cano J; Machado A
Eur J Pharmacol; 1995 Nov; 291(3):407-15. PubMed ID: 8719427
[TBL] [Abstract][Full Text] [Related]
5. A new in vitro approach for investigating the MPTP effect on DA uptake.
Barc S; Page G; Fauconneau B; Barrier L; Huguet F
Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
Carr LA; Basham JK; York BK; Rowell PP
Eur J Pharmacol; 1992 May; 215(2-3):285-7. PubMed ID: 1396992
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
[TBL] [Abstract][Full Text] [Related]
9. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
11. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
Santiago M; Machado A; Cano J
J Neurochem; 1996 Mar; 66(3):1182-90. PubMed ID: 8769882
[TBL] [Abstract][Full Text] [Related]
12. Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
Caliguri EJ; Johannessen JN
Brain Res; 1991 May; 548(1-2):94-9. PubMed ID: 1714336
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1996 Jul; 52(1):29-34. PubMed ID: 8678905
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration.
Saporito MS; Heikkila RE; Youngster SK; Nicklas WJ; Geller HM
J Pharmacol Exp Ther; 1992 Mar; 260(3):1400-9. PubMed ID: 1312170
[TBL] [Abstract][Full Text] [Related]
15. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
[TBL] [Abstract][Full Text] [Related]
16. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
[TBL] [Abstract][Full Text] [Related]
17. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice.
Sundström E; Goldstein M; Jonsson G
Eur J Pharmacol; 1986 Nov; 131(2-3):289-92. PubMed ID: 3493159
[TBL] [Abstract][Full Text] [Related]
18. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA.
Sershen H; Debler EA; Lajtha A
J Neurosci Res; 1987; 17(3):298-301. PubMed ID: 3496464
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
20. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
